Is taking iron every other day better than daily?

Your gut does not absorb a fixed share of whatever iron you swallow. The liver hormone hepcidin decides how much gets through, and hepcidin rises after an iron dose. The question that set off a decade of trials was how long that rise lasts.

Moretti and colleagues at ETH Zurich answered it in 2015, in 54 young women who were not anemic but had a ferritin of 20 µg/L or less. Twenty-four hours after any dose of 60 mg of iron or more, serum hepcidin was still raised and the share of the next dose absorbed fell by 35% to 45%. Bigger doses did not solve the problem: a sixfold increase in dose, from 40 to 240 mg, produced only a threefold increase in iron absorbed, from 6.7 to 18.1 mg. Adding a third dose within 24 hours did not significantly raise the total absorbed above two morning doses. The authors wrote that the duration of the hepcidin response supports alternate-day supplementation, and that the longer-term effects needed testing.

The same group then tested schedules head to head with stable iron isotopes, which measure exactly how much of each dose ends up in red blood cells. In the 2017 trials the women were 18 to 40 and iron-depleted, with a ferritin of 25 µg/L or less; the 2020 study enrolled women who already had iron deficiency anemia.

On our arithmetic, the alternate-day group in the 2017 trial absorbed about a third more iron (175.3 against 131.0 mg) from the same 14 doses, though it took 28 days rather than 14 to swallow them. The 2020 study extended the finding to women who were already anemic, and added one further result: 200 mg given on alternate days delivered about twice the absorbed iron of 100 mg given on consecutive days.

Twice-daily dosing, the old textbook approach, came out worst on hepcidin in the 2017 trial and no better on absorption than a single morning dose.

Since 2020, at least six randomized trials have compared the schedules on blood results. They differ in who they enrolled, how long they ran and, critically, whether both groups got the same total iron. Read each row with that last column in mind.

The pattern is clearer than the scatter suggests. When alternate-day dosing gets less total iron, as in the Kaundal and Düzen Oflas trials, it raises hemoglobin more slowly or the same, never faster. When total iron is matched, alternate days roughly keep pace, and the longest trial, von Siebenthal, found the same ferritin with fewer side effects. The one short pilot that favored daily dosing ran for only 14 days.

A 2025 systematic review in BMC Pharmacology and Toxicology pooled 11 randomized trials with 1,014 participants. The pooled hemoglobin difference favored daily dosing by 0.28 g/dL and was not statistically significant (95% CI -0.01 to 0.56, p = 0.06): the interval includes no difference at all, and the authors note that 0.28 g/dL falls well short of the roughly 1.0 g/dL they treat as a clinically meaningful difference. Ferritin and the other iron measures did not differ, overall adverse effects were similar (risk ratio 1.07, 95% CI 0.86 to 1.34), and a metallic taste was more common with daily dosing. The reviewers rated the certainty of evidence very low for most outcomes.

The British Society of Gastroenterology's 2021 guideline for iron deficiency anemia in adults states: "We recommend that the initial treatment of IDA should be with one tablet per day of ferrous sulphate, fumarate or gluconate. If not tolerated, a reduced dose of one tablet every other day, alternative oral preparations or parenteral iron should be considered." Its text calls a once-daily dose of 50 to 100 mg of elemental iron, taken fasting, one that "may be the best compromise option for initial treatment", and notes that the effect of alternate-day therapy on adherence and the final blood count response is unclear.

The American Gastroenterological Association's 2024 Clinical Practice Update goes slightly further. Its Best Practice Advice 2 reads: "Give oral iron once a day at most. Every-other-day iron dosing may be better tolerated for some patients with similar or equal rates of iron absorption as daily dosing." The AGA notes that its advice statements come from a literature review and expert opinion without formal evidence ratings.

Neither body tells adults to take iron more than once a day, and both put every-other-day dosing on the table.

All of the absorption studies and four of the six treatment trials enrolled only women, mostly of reproductive age. None of the abstracts we read reports results separately for men or for adults over 50. That matters for readers in their 40s, 50s and 60s for a reason beyond dosing: the BSG guideline says about a third of men and postmenopausal women presenting with iron deficiency anemia have an underlying abnormality, most commonly in the gut, and recommends gastroscopy and colonoscopy as the usual first investigations for them.

In other words, for a man or a postmenopausal woman, the schedule of the tablets is the second question. The first is why the iron is low.

Start with the number that prompted the question. Our ferritin reference page lists the deficiency thresholds with their sources, and our guide to the ferritin normal range explains why a lab's lower limit and the WHO's cutoff disagree. If your hemoglobin is also low, our guide to normal hemoglobin levels covers the cutoffs, and the mild anemia band page sets out the BSG's retest timing. The lab result lookup places a specific value against those ranges, and your personal screening plan shows which tests fit your age and sex.

If you are already taking iron and it upsets your stomach, alternate-day dosing is a schedule both guidelines above recognize; ask whoever is managing your iron before changing it, because most trials that matched total iron did so by doubling the dose on the days it was taken, and one, the longest, did so by running for twice as long. Whatever the schedule, the BSG recommends checking the hemoglobin response within the first 4 weeks and, for alternate-day regimens, suggests a review at about 28 days.